Moving away from candidate genes: a 'genome-wise' discovery of gemcitabine myelotoxicity.
University of North Carolina at Chapel Hill, Institute for Pharmacogenomics & Individualized Therapy, Eshelman School of Pharmacy, School of Medicine, Chapel Hill, NC 27599-7361, USA. innocent@unc.edu
Federico
F
Innocenti